- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
KLAR
STO
Week ended 07 Aug 2026
Weekly Investor Report
Klaria Pharma Holding AB (publ.) · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
0.96 SEK
11.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 9.0% above the Trend Line and sits at 58.3% of its 52-week range. The latest completed week returned 11.3%, after a 25.6% four-week move. The latest news-sentiment score is 40/100.
Setup score
53
out of 100
Latest Close
0.96 SEK
7 Aug 2026
1W Return
11.3%
latest completed week
4W Return
25.6%
short-term follow-through
12W Return
0.8%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 43.21% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
11.3%
Latest completed week; four-week move 25.6%.
Indicator stack
26/46
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.21%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
40/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 9.0% above the Trend Line and sits at 58.3% of its 52-week range. The latest completed week returned 11.3%, after a 25.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2912-week average 0.50
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.29Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 25.6% over four weeks, 0.8% over 12 weeks, and 77.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.45Latest activity-pressure read.
Pressure change55.8%Four-week change in activity pressure.
Leadership15.86Latest relative-leadership reading.
RS change807.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment40/100
Weighted news tone is negative across 3 relevant articles.
1 positive · 1 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.0%Distance below the 52-week high.
13-week volatility7.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+28.2%Week of 10 Apr.
Worst week-17.3%Week of 22 May.
Latest week+11.3%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks0
Modest losses6
Sharp losses8
Recent vol7.4%13-week weekly-return volatility.
Base vol11.6%52-week weekly-return volatility.
Up/down split26/25Count of positive and negative weeks in the 52-week window.
Average skew10.1% / -6.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank2 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Drug Manufacturers - Specialty & Generic
4-week rank2 / 19
Group average1.8%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD36.8%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis34/100Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 10/12.
Activity pressure 0.29; No reversal markers Next-Week ExpectancyNegative 43.21%Next-week expectancy is negative with a 43.21% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment40/100Weighted news tone is negative across 3 relevant articles.
KLAR Stock Gets Whacked After Q4 Loss, Weak Forecast: Retail Investors Are Shrugging It Off Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.96 SEK | 11.3% | 0.88 SEK | 0.64 SEK | -0.45 | 15.86 | 4.7M | Off |
| 31 Jul 2026 | 0.86 SEK | 9.1% | 0.88 SEK | 0.64 SEK | -0.90 | 6.89 | 3.1M | Off |
| 24 Jul 2026 | 0.79 SEK | -1.3% | 0.87 SEK | 0.63 SEK | -1.12 | -0.06 | 1.3M | Off |
| 17 Jul 2026 | 0.80 SEK | 4.7% | 0.87 SEK | 0.63 SEK | -1.07 | 3.16 | 3.2M | Off |
| 10 Jul 2026 | 0.76 SEK | -4.8% | 0.86 SEK | 0.63 SEK | -1.03 | -2.24 | 3.3M | Off |
| 3 Jul 2026 | 0.80 SEK | 2.6% | 0.86 SEK | 0.63 SEK | -1.02 | 0.82 | 655.6K | Off |
| 26 Jun 2026 | 0.78 SEK | -1.6% | 0.85 SEK | 0.63 SEK | -1.04 | 1.87 | 737.0K | Off |
| 19 Jun 2026 | 0.79 SEK | -1.0% | 0.84 SEK | 0.63 SEK | -0.90 | 3.44 | 2.8M | Off |
| 12 Jun 2026 | 0.80 SEK | 1.4% | 0.83 SEK | 0.63 SEK | -0.80 | 7.28 | 1.5M | Off |
| 5 Jun 2026 | 0.79 SEK | -0.4% | 0.82 SEK | 0.62 SEK | -0.52 | 6.52 | 778.0K | Off |
| 29 May 2026 | 0.79 SEK | 1.0% | 0.81 SEK | 0.62 SEK | -0.30 | 6.85 | 5.7M | On |
| 22 May 2026 | 0.79 SEK | -17.3% | 0.80 SEK | 0.62 SEK | -0.33 | 6.21 | 5.8M | On |
| 15 May 2026 | 0.95 SEK | 13.0% | 0.79 SEK | 0.62 SEK | -0.19 | 32.10 | 6.3M | On |
| 8 May 2026 | 0.84 SEK | -4.1% | 0.77 SEK | 0.61 SEK | -0.18 | 15.14 | 6.1M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.